Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

Anjali S. Advani, MD, Sarah Gibson, MD, Tao Jin, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael A. Sekeres, MD, Ed Copelan, MD, Shawnda Sungren, BBA, Eric D. Hsi, MD

Blood (2007) 110 (11): 2798.

https://doi.org/10.1182/blood.V110.11.2798.2798

Published: 2007

Journal Articles

Time to Post-Remission Therapy (PRT) Is an Independent Prognostic Factor for Relapse and Overall Survival in Adults with Acute Lymphocytic Leukemia (ALL).

Anjali Advani, MD, Tao Jin, MS, Ramon Tiu, MD, Giridharan Ramsingh, MD, Christopher Lowe, PharmD, Wael Saber, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Shawnda Sungren, BBA, Matt Kalaycio, MD

Blood (2006) 108 (11): 1883.

https://doi.org/10.1182/blood.V108.11.1883.1883

Published: 2006

Journal Articles

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Anjali S. Advani, MD, Sarah Gibson, MD, Tao Jin, MS, Ramon Tiu, MD, Giridharan Ramsingh, MD, Matt Kalaycio, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Shawnda Sungren, BBA, Eric D. Hsi, MD

Blood (2006) 108 (11): 1846.

https://doi.org/10.1182/blood.V108.11.1846.1846

Published: 2006

Journal Articles

Chemotherapy-Related Amenorrhea (CRA) among Premenopausal Patients Treated for Acute Leukemia.

Suzanne R. Fanning, DO, Tao Jin, MS, Joanne M. Hilden, MD, Anjali Advani, MD, Matt Kalaycio, MD, Alan E. Lichtin, MD, Mikkael A. Sekeres, MD, MS, Ronald Sobecks, MD, Halle C.F. Moore, MD

Blood (2006) 108 (11): 3315.

https://doi.org/10.1182/blood.V108.11.3315.3315

Published: 2006

Journal Articles

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Cristina Rodriguez, MD, Tao Jin, MS, Rony Abou Jawde, MD, Wael Saber, MD, Rachid Baz, MD, Eric His, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Anjali Advani, MD

Blood (2006) 108 (11): 4510.

https://doi.org/10.1182/blood.V108.11.4510.4510

Published: 2006

Journal Articles

Double Negative T Cells Influence TCR VB Variablity to Induce Allotolerance.

Zachariah A. McIver, DO, Marcin Wlodarski, MD, Jennifer Powers, BS, Christine O’Keefe, PhD, Tao Jin, MS, Ronald Sobecks, MD, Brian J. Bolwell, MD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2006) 108 (11): 759.

https://doi.org/10.1182/blood.V108.11.759.759

Published: 2006

Journal Articles

CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).

Wael Saber, MD, Rony Abou-Jawde, MD, Eric Hsi, MD, Tao Jin, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael Sekeres, MD, Brad Pohlman, MD, Barbara L. Tripp, RN, Anjali Advani, MD

Blood (2005) 106 (11): 3292.

https://doi.org/10.1182/blood.V106.11.3292.3292

Published: 2005

Journal Articles

Non-Myeloablative vs. Conventional Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma.

Brad Pohlman, MD, Tao Jin, MS, Elizabeth Kuczkowski, Stacey Brown, Ronald Sobecks, MD, Matt Kalaycio, MD, Steven Andresen, MD, Brian J. Bolwell, MD

Blood (2005) 106 (11): 1132.

https://doi.org/10.1182/blood.V106.11.1132.1132

Published: 2005

Journal Articles

Immunohistochemical Expression of CD10, BCL6, and MUM1 in Primary Nodal Diffuse Large B-Cell Lymphoma: MUM1 Expression Alone (but Not Germinal Center B-Cell Immunophenotype) Is an Independent Prognostic Factor.

Nicholas Wongchaowart, MD, Ena Segota, MD, Tao Jin, MS, Brad Pohlman, MD, Eric D. Hsi, MD

Blood (2005) 106 (11): 4706.

https://doi.org/10.1182/blood.V106.11.4706.4706

Published: 2005

NARROW

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

Time to Post-Remission Therapy (PRT) Is an Independent Prognostic Factor for Relapse and Overall Survival in Adults with Acute Lymphocytic Leukemia (ALL).

Blasts Express Phospho-Akt in the Majority of Adult Patients with Acute Lymphocytic Leukemia (ALL).

Chemotherapy-Related Amenorrhea (CRA) among Premenopausal Patients Treated for Acute Leukemia.

c-Kit (CD117) Expression Is a Poor Prognostic Factor for Relapse and Overall Survival in Patients with Newly Diagnosed AML.

Double Negative T Cells Influence TCR VB Variablity to Induce Allotolerance.

CD117 Expression Is a Poor Prognostic Factor (PF) for Progression Free Survival (PFS) and Freedom from Progression (FFP) in Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML).

Non-Myeloablative vs. Conventional Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma.

Immunohistochemical Expression of CD10, BCL6, and MUM1 in Primary Nodal Diffuse Large B-Cell Lymphoma: MUM1 Expression Alone (but Not Germinal Center B-Cell Immunophenotype) Is an Independent Prognostic Factor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only